CHST3, carbohydrate sulfotransferase 3, 9469

N. diseases: 214; N. variants: 18
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 Biomarker disease BEFREE The structures of the highly homologous type I and II 3 beta-HSD genes have been analyzed in three male pseudohermaphrodite 3 beta-HSD deficient patients from unrelated families in order to elucidate the molecular basis of classical 3 beta-HSD deficiency from patients exhibiting various degrees of severity of salt losing. 8316254 1993
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 GeneticVariation disease BEFREE These findings suggest that the degree of ACTH-stimulated delta 5 precursor steroid abnormality, such as delta 5-17P levels up to 10 SD above the normal mean level found in our PP patients, is not caused by a mild variant of 3 beta HSD deficiency CAH resulting from type II or type I 3 beta HSD gene mutation. 8923844 1996
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 GeneticVariation disease BEFREE Molecular DNA analysis was also performed in 6 of the patients, using the strategy successfully used to detect point mutations in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene, which are responsible for classical 3 beta HSD deficiency. 7989489 1994
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 GeneticVariation disease BEFREE In conclusion, a structurally lengthy MT II 3beta-HSD enzyme due to a nonstop mutation was relatively detrimental in intact cells causing the nonclassic phenotype of 3beta-HSD deficiency. 12050213 2002
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 GeneticVariation disease BEFREE These data indicate a homozygous combined missense/frameshift mutation in exon IV of the type II 3 beta-HSD gene resulting in severe salt-wasting adrenal and gonadal 3 beta-HSD deficiency in the patient. 8284113 1993
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 AlteredExpression disease BEFREE In hyperandrogenic children and women, the pathogenic mechanism of a subtle abnormality in adrenal 3 beta-HSD activity, determined by modestly elevated ACTH stimulated delta-5 steroid levels, which led to the diagnosis of mild nonclassic 3 beta-HSD deficiency in the past, is outside of the type II 3 beta-HSD gene which encodes adrenals and gonads in humans and remains to be further explored. 11344940 2001
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 GeneticVariation disease BEFREE We report mutations of the type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene in two siblings, male and female, with congenital adrenal hyperplasia caused by classical nonsalt-losing 3 beta HSD deficiency. 7962268 1994
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 Biomarker disease BEFREE To better understand the molecular basis of the phenotypic heterogeneity found in 3 beta HSD deficiency, we analyzed the structure of type I and II 3 beta HSD genes in a female patient with nonsalt-losing 3 beta HSD deficiency diagnosed at puberty. 8126127 1994
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 Biomarker disease BEFREE Both codon 273 and 318 mutations yielding frameshift and premature stop codons at codons 279 and 367, respectively, are predicted to result in an altered and truncated type II 3 beta-HSD protein, thereby causing salt-wasting 3 beta-HSD deficiency in the patient. 8550766 1996
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 Biomarker disease BEFREE Our results indicate that the genital phenotype in 3beta-HSD deficiency cannot be predicted from in vitro 3beta-HSD function alone. 18252794 2008
3 beta-Hydroxysteroid dehydrogenase deficiency
0.100 Biomarker disease BEFREE Thus, the elucidation of the molecular basis of 3beta-HSD deficiency has highlighted the fact that mutations in the HSD3B2 gene can result in a wide spectrum of molecular repercussions, which are associated with the different phenotypic manifestations of classical 3beta-HSD deficiency and also provide valuable information concerning the structure-function relationships of the 3beta-HSD superfamily. 12428206 2002
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
0.010 GeneticVariation disease BEFREE No linkage to the 3 beta-HSD gene cluster in a kindred affected with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency and early onset hepatic failure. 7759084 1995
Abnormal form of the vertebral bodies
0.100 Biomarker phenotype HPO
Abnormality of cardiovascular system morphology
0.100 Biomarker disease HPO
CUI: C4021664
Disease: Abnormality of the abdominal wall
Abnormality of the abdominal wall
0.100 Biomarker disease HPO
CUI: C1855852
Disease: Abnormally large globe
Abnormally large globe
0.100 Biomarker phenotype HPO
CUI: C0158465
Disease: Acquired cubitus valgus
Acquired cubitus valgus
0.100 Biomarker disease HPO
CUI: C0600033
Disease: Acquired Kyphoscoliosis
Acquired Kyphoscoliosis
0.100 Biomarker disease HPO
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.010 GeneticVariation disease BEFREE Here we reported 1 patient with APL with CHST3 mutations. 30200136 2018
CUI: C0001430
Disease: Adenoma
Adenoma
0.010 AlteredExpression group BEFREE In vitro enzyme assay using microsomal fraction of adenoma indicated that all adenomas from seven patients showed almost the same degree of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) activities. 8496319 1993
CUI: C0001624
Disease: Adrenal Gland Neoplasms
Adrenal Gland Neoplasms
0.010 Biomarker group BEFREE Histopathological analysis of the resected adrenal tumors from 5 PA/SCS patients revealed a single adenoma in 3, and double adenomas in 2, with varying degrees of positive immunoreactivities for steroidgenic enzymes (3β-HSD, P450(C17)) by immunohistochemical study as well as CYP11B2 mRNA expression as measured by real-time RT-PCR. 21521926 2011
CUI: C0206686
Disease: Adrenocortical carcinoma
Adrenocortical carcinoma
0.010 AlteredExpression disease BEFREE EGF treatment (25 ng/ml) of human adrenocortical carcinoma cells (H295R) resulted in a 5-fold increase in cortisol production and a corresponding 2-fold increase in 3 beta HSD mRNA. 12697691 2003
CUI: C0162309
Disease: Adrenoleukodystrophy
Adrenoleukodystrophy
0.010 AlteredExpression disease BEFREE Previously we have shown higher urinary F:E metabolite ratios (a reflection of global 11beta-HSD activity) in patients with alcoholic liver disease (ALD) compared to patients with chronic liver disease (CLD) of other aetiologies, suggesting that the phenotype of alcoholic pseudo-Cushing's may relate to altered metabolism of F. 18031327 2008
CUI: C0278595
Disease: Adult Fibrosarcoma
Adult Fibrosarcoma
0.010 AlteredExpression disease BEFREE Osteosarcoma-derived OB cell lines TE-85, MG-63 and SaOS-2 and fibrosarcoma Hs913T cells express the type 2 isoform of 11beta-HSD, as determined by reverse transcription polymerase chain reaction (RT-PCR) and specific enzyme assays. 10333548 1999
CUI: C0545053
Disease: Advanced bone age
Advanced bone age
0.100 Biomarker phenotype HPO